Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome
Launched by CAIRO UNIVERSITY · Apr 27, 2015
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
Premenstrual syndrome (PMS) manifests with distressing physical, behavioral and psychological symptoms, in the absence of organic or underlying psychiatric disease, which regularly recur during luteal phase of each menstrual cycle and disappear or significantly improve by the end of menstruation. Approximately 85-90 % of women may experience premenstrual emotional and physical changes in their reproductive age and the prevalence of severe PMS ranges from 3% to 8%.
The etiology of PMS is unknown but cyclical ovarian activity and the effect of estradiol and progesterone on serotonin and gamm...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • PMS
- • Consents to the procedure
- Exclusion Criteria:
- • Previous medical treatment for PMS
- • Body mass index \> 35 kg/m2
- • Irregular periods
- • Medical disorders like diabetes, hypertension, cardiac, liver, kidney or heart disease
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials